# IVIG in Patients With Severe COVID-19 Requiring Mechanical Ventilation

> **NCT04616001** · PHASE4 · UNKNOWN · sponsor: **Sharp HealthCare** · enrollment: 10 (estimated)

## Conditions studied

- Covid19
- SARS-CoV Infection

## Interventions

- **DRUG:** IVIG

## Key facts

- **NCT ID:** NCT04616001
- **Lead sponsor:** Sharp HealthCare
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-11-01
- **Primary completion:** 2021-06-30
- **Final completion:** 2021-06-30
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2020-11-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04616001

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04616001, "IVIG in Patients With Severe COVID-19 Requiring Mechanical Ventilation". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04616001. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*